KIF1A promotes neuroendocrine differentiation in prostate cancer by regulating the OGT-mediated O-GlcNAcylation

Qianqian Zhou1, Muyi Yang2, Jiawei Fu1

  • 1The Key Laboratory of Experimental Teratology, Ministry of Education and Department of Pathology, School of Basic Medical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, 250000, P R China.

Cell Death & Disease
|November 6, 2024
PubMed

Insights

Kinesin-like protein 1A (KIF1A) drives neuroendocrine prostate cancer (NEPC) progression by enhancing O-linked N-acetylglucosamine transferase (OGT) activity. Targeting KIF1A or O-GlcNAcylation may offer new therapeutic strategies for NEPC.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Neuroendocrine prostate cancer (NEPC) is an aggressive subtype of prostate cancer with poor prognosis.
  • Understanding the molecular mechanisms of NEPC development is crucial for identifying new therapeutic targets.

Purpose of the Study:

  • To investigate the role of Kinesin-like protein 1A (KIF1A) in NEPC development and identify its downstream molecular targets.
  • To explore the therapeutic potential of targeting KIF1A and O-linked N-acetylglucosamine transferase (OGT) in NEPC.

Main Methods:

  • Pan-cancer differential mRNA abundance analysis to identify key genes.
  • KIF1A knockdown and overexpression experiments in prostate cancer cell lines.
  • In vitro and in vivo assays to assess tumor growth and NE differentiation.
  • Co-immunoprecipitation and Western blot analyses to investigate protein interactions and modifications.

Main Results:

  • KIF1A was highly expressed in NEPC and promoted neuroendocrine differentiation, stemness, and epithelial-mesenchymal transition (EMT).
  • KIF1A directly interacted with OGT, enhancing its activity and promoting intranuclear O-GlcNAcylation of key transcription factors.
  • Targeting KIF1A or OGT with inhibitors significantly suppressed NEPC cell proliferation and tumor growth in vitro and in vivo.

Conclusions:

  • KIF1A promotes NEPC development by regulating OGT-mediated O-GlcNAcylation, representing a potential therapeutic vulnerability.
  • Targeting KIF1A or O-GlcNAcylation pathways may offer novel treatment strategies for patients with advanced prostate cancer and NEPC phenotype.

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.5K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.7K
Enzyme-linked Receptors01:00

Enzyme-linked Receptors

Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
77.4K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.4K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
Proteoglycans01:05

Proteoglycans

Glycans, a class of complex heterogeneous molecules, can be covalently attached to proteins to form glycosylated proteins that regulate various physiological and pathological processes. Glycosylated proteins or glycoproteins comprise N-linked and O-linked oligosaccharides. O-glycosylation is the most common type of protein glycosylation. Here, glycans attach to the oxygen atom of the hydroxyl groups of Serine or Threonine residues. O-linked glycosylation occurs later in protein processing,...
3.9K